Purpose: To compare two doses of bolus epidural morphine with bolus iv morphine for postoperative pain after abdominal or genitourinary surgery in infants. Methods: Eighteen infants were randomly assigned to bolus epidural morphine (0.025 rag. kg -I or 0.050 rag. kg -I ) or bolus iv morphine (0.050-0.150 mg .kg-t Accepted for publication July 20, 1996. negligible in LE (<2 ng. ml-t), were similar in the HE and iv groups (peak 8.5 +_ 12.5 and 8.6 +_ 2.4 ng. ml -I, respectively 
Objectif" Comparer deux doses ~pidurales de morphine en bolus avec un bolus de morphine iv administrdes pour la douleur postopYratoire apr~s une chirurgie abdominale ou urogdnitale chez l' enfant. M~thodes: Dix-huit enfants ont dtd rgpartis pour recevoir soit un bolus de morphine dpidural (0,025 mg.kg -I ou 0,05 rag. kg -I) soit un bolus de morphine iv (0,050-0,150 rag. kg-t ).
 (3,8 • 0,8 
pour la dose ldg~re [DL], 3,5 • 0,8pour la dose forte [DF] vs 6,7 • 1,6 pour la morphine iv, P < 0,05) d demande a dtd requis pour les groupes recevant la morphine dpidurale. Pour obtenir des scores satisfaisants sur l'dcheUe de la douleur, on a d~ modifier les doses dans tousles groupes. On a not~ du prurit, de l'apnde et une d~saturation en oxyg~ne dans tous les groupes. Les courbes identiques en pr~op~ratoire de la rgponse au C02 (~cart, 36-41 ml.min-l.mmHg ETco2 -I. kg -I) dtaient g~n~ralement ddprim~es (dcart, 16-27 ml . rain -1. mmHg ETco2 -1-kg-I ). Les concentrations de morphine sdrique, ndgligeables pour DL (<2 ng.ml-t), s identiques pour DF et iv (maximum respectif 8,5 • 12,5 et 8,6 +_ 1,4 ng. ml-I). Conclusion: La morphine dpidurale et la morphine iv procurent une analg~sie postopgratoire suffisante aux enfant malgrd des effets secondaires fr~quents. La morphine dpidurale a
Although intravenous morphine has been the mainstay of postoperative pain control in infants and children, epidural morphine has been shown to be effective. '-8 Infants may be at greater risk for respiratory depression associated with the use of intravenous and epidural morphine 8 than are children and adults. The pharmacokinetic behaviour of opioids 9-1~ is altered in neonates and young infants, t2 and this may explain the increase in opioid-induced ventilatory depression. It is not known whether intravenous or epidural morphine is the more advantageous with respect to safety, efficacy, or clinical use in providing postoperative analgesia in infants. This study was designed to compare the effectiveness, use, side effects, respiratory effects, and pharmacology of bolus epidural morphine in two doses with bolus intravenous morphine administered to infants for the control of postoperative pain following abdominal or genitourinary surgery.
Methods
After approval by the Institutional Human Subjects Review Board of Children's Hospital and Medical Center, ASA I and II infants aged 3-12 mo undergoing abdominal or genitourinary surgery were enrolled in this study after obtaining parental consent and were randomly assigned to one of three bolus treatment groups for control of postoperative pain: Group 1, epidural morphine 0.025 mg-kg-t; Group 2, epidural morphine 0.050 mg-kg-~; Group 3, intravenous morphine 0.050-0.150 mg.kg -j. Perioperative management is described in Figure 1 . Treatment was not blinded because it was considered unacceptable to place sham epidural catheters in infants in Group 3.
General anaesthesia was induced without premedication and maintained with a volatile anaesthetic and a neuromuscular blocking agent; no opioids or local anaesthetic agents were used intraoperatively. At the conclusion of the surgical procedure, a 20 g caudal epidural catheter (Burron| Medical Inc., Bethlehem, PA) was placed via an 18 g intravenous cannula (Terumo | Medical Corp., Elkton, MD) to a distance <8 cm from skin entry in those patients assigned to Groups 1 and 2, but not those in Group 3. All the infants' tracheas were extubated when the infants were awake, neuromuscular blockade had been reversed, and the end- After admission, vital signs were determined in the Post Anaesthesia Care Unit (PACU), the predetermined epidural morphine dose was administered to the infants in Groups 1 and 2, and intravenous morphine was administered in increments of 0.050 mg. kg-' in infants in Group 3 to achieve a pain scale score >16. Analgesia was assessed by the bedside nurse by a modification of the infant pain scales described by Barrier et al., and Grunau and Craig, 13,14 a 20-point scale based on 10 observed characteristics (Figure 2 ). Subsequent treatment was provided when the pain scale score was <10, and treatment was considered successful if a score >16 was obtained. In Groups I and 2, rescue treatments with epidural morphine 0.025 mg.kg -] and subsequent interval dose increases of 0.025 mg-kg -t were provided if the duration of analgesia was less than six hours; in Group 3, rescue and interval dose increases of 0.050 mg.kg -] were provided if analgesia lasted less than four hours. Morphine treatment doses were eliminated in Group 1, decreased by 0.025 mg .kg -] in Group 2, and decreased by 0.050 mg.kg -~ in Group 3 if side effects were considered excessive (i.e., frequent episodes of apnoea, bradycardia, and haemoglobin desaturation; sedation unresponsive to gentle stimulation; pruritus unresponsive to pharmacological intervention). Infants were maintained on the treatment regimen until the third postoperative day, oral analgesics were tolerated, or side effects warranted discontinuation of therapy.
All infants were monitored continuously in the post- 
FIGURE 2 Modified infant pain scale (20 points for comfort).
Infants were medicated for scores <10; scores >16 were considered adequate analgesia.
operative period with ECG, impedance pneumogram and pulse oximeter. In addition, for the first 24 hr after surgery, all infants were monitored with continuous multi-channel recordings, including ECG, pulse oximeter, and both impedance and nasal thermistor pneumogram. These digitized recordings were made on a Healthdyne| system (Healthdyne Corp., Marietta, GA), which utilized an Ohmeda| Model 3740 pulse oximeter (Ohmeda Medical Systems, Madison, WI). All studies were performed in the fast response mode, such that haemoglobin oxygen saturation (SpO2) was averaged over three seconds and the pulse interval for calculation of heart rate was averaged over five seconds. The multichannel recordings were subsequently analyzed for dysrhythmia, respiratory variation, and haemoglobin desaturation. Apnoea was defined as cessation of all nasal air flow for 10 sec, bradycardia as heart rate <90 bpm. A hypoxic event was considered minor if the lowest SpO2 was 80-89% for a period of less than one minute; an event was considered major if the SpO2 was <80% or if an event with SpO2 80--89% persisted more than one minute. Physical stimulation and/or supplemental oxygen were given to the infant at the discretion of the bedside caregiver for apnoea or desaturation. Infants were assessed for comfort by the bedside nurse. Pain was measured by the modified infant pain scale every four hours postoperatively and at any time discomfort was apparent. All possible side effects of morphine (e.g., sedation, apnoea, bradycardia, haemoglobin desaturation, urinary retention, vomiting, and pruritus) were also assessed and recorded by the bedside nurse.
Response to CO2 was assessed by the re-breathing technique )5 with the use of a close-fitting cushion mask at the following times: prior to induction of anesthesia; on arrival to PACU prior to morphine administration; at discharge from PACU one hour after morphine administration; and on the first postoperative day, one hour after a morphine administration.
Serum morphine concentrations were determined using 1 ml blood samples obtained prior to the initial morphine administration, and at 15, 30, 60, and 120 min after morphine administration in the PACU. The blood was obtained from indwelling arterial or venous catheters through which no morphine had been administered. The samples were collected and sampled by high performance liquid chromatography (HPLC), as previously described. '~ The method is sensitive to 1 ng. m1-1 with linear reproducibility over the range 1 to 500 ng-ml-'; for determination of between-run precision on 50 lal samples, control samples of 5, 25, and 100 ng.ml -~ showed coefficients of variation of 16.2%, 8.1% and 4.1%, respectively. J6 Morphine concentration was analyzed by area under curve methodology to calculate clearance and the fraction of morphine available systemically after epidural administration. ~7
Statistical calculations were performed with SPSS for Windows (SPSS Inc., Chicago, ILL). Continuous variables measured at a single time in the three groups were compared by one way ANOVA with Tukey's adjustment for post hoc pair wise comparisons. Group differences between variables that were sampled at multiple times on each subject were analyzed with MANOVA. A paired t test was used to compare the control slope of the CO2 response curve with the postoperative day 1 slope for each group. All data are presented as mean _+ S.D., and significance was defined as P < 0.05.
Results
Eighteen infants were enrolled in this study. One additional infant who had been enrolled in Group 2 was removed from the study because placement of his caudal epidural catheter postoperatively was unsuccessful. The three groups of infants were similar in terms of postnatal age and weight, and no infant had been premature at birth (Table I ). All infants underwent abdominal or genitourinary surgical procedures with general anaesthesia that included halothane or isoflurane, with or without nitrous oxide, and a neuromuscular blocking agent (pancuronium bromide or vecuronium bromide). None of the patients had an adverse outcome. All infants had satisfactory postoperative analgesia as assessed by the modified infant pain scale. Analgesia was achieved consistently both by subjective assessment and by achievement of a pain score >16 within five minutes of morphine administration by either route.
The profile of morphine administration was different among the epidural groups and the intravenous group (Table II) . Infants receiving intravenous morphine required the second dose administration four hours after the initial dose, compared with seven to eight hours for the infants receiving epidural morphine; the third administration in the intravenous group also occurred after a shorter interval than did the high dose epidural group (P < 0.05). The total number of doses and total amount of administered morphine for the first 24 hr after surgery were greater in the intravenous group than in either of the epidural groups. Dose regimen adjustments were necessary in all three groups. Two infants in the low dose epidural group required increases, although in one case the increase in analgesic requirement was probably related to a postoperative surgical complication (described below). Two infants in the high dose epidural group required a decrease and/or termination of therapy due to severe pruritus. Infants in the intravenous group required 0.050-0.150 mg.kg -1 for initial pain control, and three of these infants required subsequent dose increases.
Side effects of therapy were common (Table III) . Pruritus occurred in infants in all three groups and usually presented with infants rubbing their eyes with their hands or rubbing their faces in the bed clothing. Treatment included diphenhydramine alone (n = 8) or in combination with naloxone (n = 4). In two patients in the high dose epidural group, as noted above, persistent pruritus despite treatment led to discontinuation of epidural therapy. In one patient in the intravenous group, discomfort caused by unrecognized pruritus was treated as pain with increasing doses of morphine; monitoring documented 20 subsequent episodes of apnoea and 38 episodes of haemoglobin desaturation (SpO2 as low as 70%). Excessive clinical sedation and isolated bradycardia were uncommon in any group.
Apnoea-bradycardia events, as well as minor and major hypoxaemic events, were documented by 24-hr multi-channel recordings (Figure 3) in many of the patients. However, eight of the 18 infants had no documented apnoea and, excluding the one infant in Group 3 described above, the six infants with major hypoxaemic events had, on average, two such events per infant. Sixty percent of the apnoeic events were obstructive; 75% of hypoxaemic events occurred without apnoea, although often with disorganized respiration; and 42% of the apnoeic events occurred without hypoxaemia. Seventy-five percent of the hypoxaemic events in the epidural groups occurred >2 hr following morphine administration, whereas 89% of such events in the intravenous group occurred <2 hr following morphine administration.
Other side effects included a surgical complication (intussusception following a Duhamel procedure) in one infant in the low dose epidural group, who was consequently removed from the study at the end of the first postoperative day. Supplemental analgesics during the period of study were required by at least one patient in each group, although acetaminophen alone was given in most cases. Urinary retention and nausea-vomiting could not be assessed since all patients had indwelling bladder drainage and 11 had nasogastric tubes.
Serial determination of CO2 response curve slopes demonstrated no differences among the three groups, and interpatient variability was considerable (Table IV) . Preoperative unsedated response curve slopes were similar among the groups (range, 36-41 ml-min -~-mmHg ETcoz -~. kg-~). Response curve slopes determined on postoperative day one, one hour after morphine administration, were similar among the flame groups. This slope was less than the preoperative slope in the high dose epidural (P < 0.02) and intravenous groups (P < 0.004). Response curve slopes did not correlate with the occurrence of apneic or desaturation events in individual infants.
Serial determinations of serum morphine concentrations demonstrated negligible concentrations in the low dose epidural group (i.e., <2 ng. ml -I) ( Table V) . Serum concentrations in the high dose epidural and the intravenous groups were similar and higher than those of the low dose epidural group at 15, 30, and 60 min. Only one patient had serum concentrations of morphine >15 ng. ml -~, a patient in the high dose epidural group with a concentration of 23.3 ng. ml -~ at 30 min and 34 ng. ml -~ at 60 min after administration. The clearances estimated for the intravenous group (19.8 _+ 5.9 ml.min-l.kg -j) and for the high dose epidural group (59.4 _+. 3.2 ml.min -~ .kg -1) yield a systemic availability for morphine of 0.33 after epidural administration.
Discussion
This study has demonstrated that, in infants undergoing abdominal and genitourinary surgery, all three morphine regimens provided rapid and effective postoperative analgesia, as assessed by a modified infant pain scale, with minimal need for supplementary medications. Epidural morphine had the advantage of providing saris-factory analgesia with fewer administrations and less total morphine administered in the first postoperative day, and bolus epidural morphine, 0.025 mg.kg -1 appeared to be an effective starting dose in several patients. Pruritus and some degree of cardiorespiratory compromise (apnoea, bradycardia, haemoglobin desaturation, and depression of CO2 response) occurred in many of the infants receiving either epidural or intravenous bolus morphine.
Several previous reports including both infants and children have established the effectiveness of epidural morphine 0.050-0.070 mg-kg -I in the control of postoperative pain, 6, 8, 18, 19 although these reports made no attempt to determine the optimal dose or to compare epidural with other routes of administration. The higher doses utilized in these studies provided longer duration of analgesia (mean duration >10 hr) than we found in our epidural groups (mean 7-8 hr) and were associated with serious side effects: excessive sedation (0-4%); respiratory depression (0-8%), especially in infants who received intravenous opioids intraoperatively; 6,8 nausea and vomiting (0-31%); urinary retention (7-50%); and pruritus (3-88%). The variability in reported side effects may reflect both the difficulty in their ascertainment in infants generally and the different methods of assessment utilized in these reports.
Apnoea occurred in 10 of 18 infants and hypoxaemic events occurred in 16 of 18 in this study, although the number of events for most of the infants was small. This represents a higher frequency of respiratory events than previously reported for a population of healthy non-surgical infants older than two months, 2~ for infants receiving epidural morphine, 6,18,19 and for older children receiving postoperative morphine analgesia. 21 The high frequency of apnoea and desaturation seen here probably reflects the detailed method of ascertainment. That the majority of apnoeic events were obstructive indicates that they would not have been detected by chest wall impedance alone. That the majority of hypoxaemic events occurred without apnoea indicates that they would not have been detected by respiratory monitoring without pulse oximetry. Although specific apnoeic and hypoxaemic events were not correlated with serum concentrations of morphine, the timing of the majority of hypoxaemic events (<2 hr following bolus intravenous and >2 hr following bolus epidural morphine) is consistent with their occurring at peak morphine effect at central nervous system receptors. 22 Severe pruritus was seen in 13 of 18 infants in this study, a finding consistent with that of Dalens et al. 18 The difficulty in diagnosing pruritus in infants is illustrated by the patient in Group 3 whose agitation from pruritus was interpreted as pain by experienced nurses and was treated with frequent administrations of intravenous morphine for discomfort. The multiple episodes of apnoea and haemoglobin desaturation that followed morphine administration in this patient indicate the potential impact of such misdiagnosis. In addition, treatment of pruritus with antihistamines and other medications may increase the risk of excessive sedation and other side effects of morphine.
The rapid onset of analgesia after administration of bolus epidural morphine in infants has not been previously reported. Attia et al. ~ found that the onset of analgesia in children 2 to 15 yr old after epidural morphine 0.050 rag. kg -l occurred at a mean of 30 min. The negligible serum morphine concentrations at all times after low dose epidural morphine suggest that its immediate effect is not mediated by systemic absorption of the opioid. The rapid onset of effect in infants is important to note because it may render unnecessary the concomitant administration of potent opioids like fentanyl by intravenous or epidural routes to establish immediate analgesia.
Measured CO2 response slopes at preoperative baseline were similar .to those previously reported in infants 15,z3-15 and showed depression after morphine administration on postoperative day 1 in most infants. The method of slope determination utilized a close-fitting mask which stimulates the infant, and this stimulation may explain the wide variability in the CO2 response slopes obtained at the different times. Slopes obtained in individual infants were not predictive of side effects of morphine.
Serum morphine concentrations obtained were generally lower than previous published data. In seven children 2-15 yr of age who received epidural morphine 0.050 mg. kg -l , Atria et al. J found peak serum concentrations of 26.7 +__ 9.1 ng-ml -~ (range, 13.1-39) at 10.3 • 0.3 min (range, 10.0-10.7) after injection, while only one patient in our study had peak levels >15 rig-ml -I. The higher serum concentrations after epidural administration may reflect a smaller volume of distribution in children than in infants; our short period of sampling does not allow calculation of this volume. The serum concentrations >15 ng.m1-1 in one infant in Group 2 may reflect variability of absorption or delayed systemic absorption after an epidural injection of morphine that was partially intravascular. The clearance of morphine calculated for those infants receiving intravenous morphine (i.e., 19.8 ml.min-t.kg -~) is consistent with previous reports; 26,27 the clearance for those receiving epidural morphine (i.e., 59.4 ml-min -1. kg -I) is greater than twice that reported in adults. 28 In summary, we have shown in 18 infants that effective postoperative analgesia was provided by bolus mor-phine given either epidurally in two doses or intravenously, although there was no difference in safety or efficacy among the groups. Investigation of a larger number of infants might establish a correlation between morphine dose, route of administration, and incidence of side effects. Extrapolation of data from other infant populations monitored less intensively 8,29 indicates that >400 infants would have to be studied in order to establish a 10% reduction (with 95% confidence) in postoperative apnoea by one of three treatments. Our investigation indicates that pruritus, apnoea and haemoglobin desaturation occur in many infants to whom morphine is repeatedly administered intravenously or epidurally for the control of postoperative pain after major abdominal or genitourinary surgery. Although the long term consequence of desaturation events is unclear, it does seem appropriate to carefully observe this group of infants with continuous pulse oximetry.
